Anti-bacterial activity of Ricinus communis L. against bacterial pathogens Escherichia coli and Klebsiella oxytoca as evaluated by Transmission electron microscopy

References

• Cragg GM, Newman DJ. Natural products: a continuing source of novel drug leads. Biochim Biophys Acta. 2013;1830(6):3670–3695.
   PubMed Web of Science ®Google Scholar
• Ventola CL. The antibiotic resistance crisis: Part 1: causes and threats. Pharm Ther. 2015;40(4):277–283.
   Google Scholar
• Bérdy J. Thoughts and facts about antibiotics: where we are now and where we are heading. J Antibiot. 2012;65(8):441.
   PubMed Web of Science ®Google Scholar
• Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010;74(3):417–433.
   PubMed Web of Science ®Google Scholar
• Dias DA, Urban S, Roessner U. A historical overview of natural products in drug discovery. Metabolites. 2012;2(2):303–336.
   PubMedGoogle Scholar
• Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014;4:177.
   PubMed Web of Science ®Google Scholar
• Balouiri M, Sadiki M, Ibnsouda SK. Methods for in vitro evaluating anti- microbial activity: a review. J Pharmaceutical Anal. 2016;6(2):71–79.
   PubMed Web of Science ®Google Scholar
• Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev. 1999;12(4):564–582.
   PubMed Web of Science ®Google Scholar
• Pan SY, Zhou SF, Gao SH, et al. New perspectives on how to discover drugs from herbal medicines: CAM's outstanding contribution to modern therapeutics. Evid Based Complement Alternat Med. 2013;2013: 627375 . doi:10.1155/2013/627375.
   PubMed Web of Science ®Google Scholar
• Verma S, Singh SP. Current and future status of herbal medicines. Vet World. 2008;1(11):347–350.
   Google Scholar
• Tatem AJ, Rogers DJ, Hay SI. Global transport networks and infectious disease spread. Adv Parasitol. 2006;62:293–343.
   PubMed Web of Science ®Google Scholar
• Frieden T. Antibiotic resistance threats in the United States. Atlanta (GA): Centers for Disease Control and Prevention (CDC); 2013 [cited 2017 Aug 07]. p. 2–50; Available from: https://www.cdc.gov/drugresistance/threat-report-2013/index.html
   Google Scholar
• Saker L, Lee K, Cannito B, et al. Globalization and infectious diseases: a review of the linkages. Geneva: World Health Organization; 2004. (Special Topics in Social, Economic and Behavioural (SEB) Research; 3:1–67).
   Google Scholar
• Podschun R, Ullmann U. Klebsiella sp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998;11(4):589–603.
   PubMed Web of Science ®Google Scholar
• Joainig MM, Gorkiewicz G, Leitner E, et al. Cytotoxic effects of Klebsiella oxytoca strains isolated from patients with antibiotic-associated hemorrhagic colitis or other diseases caused by infections and from healthy subjects. J Clin Microbiol. 2010;48(3):817–824.
   PubMed Web of Science ®Google Scholar
• Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges, and responses. Nat Med. 2004;10(12):S122–129.
   PubMed Web of Science ®Google Scholar
• Rattan A, Raj VS, Saini KS. Recent advances in the discovery and development of new drugs against Gram-negative pathogens. In: Atta-ur-Rahman, editor. Frontiers in clinical drug research. Vol.1, Anti-infectives. UK: University of Cambridge; 2014. p. 237–262.
   Google Scholar
• Naz R, Bano A. Antimicrobial potential of Ricinus communis leaf extracts in different solvents against pathogenic bacterial and fungal strains. Asian Pac J Trop Biomed. 2012;2(12):944–947.
   PubMedGoogle Scholar
• Jena J, Gupta AK. Ricinus communis Linn: a phytopharmacological review. Int J Pharm Pharm Sci. 2012;4(4):25–29.
   Google Scholar
• Rabanal FA, Grau-Campistany X, Vila-Farres J, et al. A bioinspired peptide scaffold with high antibiotic activity and low in vivo toxicity. Sci Rep. 2015 [cited 2017 Aug 07];5:10558. DOI:10.1038/srep10558
   PubMed Web of Science ®Google Scholar
• Masoko P, Nemudzivhadi V. Isolation and chemical structural characterization of the mixture of two related phytosterols from Ricinus communis L. (Euphorbiaceae) leaves. Eu J Med Plants. 2015;10(2):1–11.
   Google Scholar
• Dhar P, Chan P, Cohen DT, et al. Synthesis, antimicrobial evaluation, and structure-activity relationship of α-pinene derivatives. J Agric Food Chem. 2014;62(16):3548–3552.
   PubMed Web of Science ®Google Scholar
• Claude TJ. Chemical composition, antibacterial and antifungal activity of the essential oil of Pinus patula growing in rwanda. Am J Biomed Life Sci. 2014;2(3):55.
   Google Scholar
• Alamri SA, Moustafa MF. Antimicrobial properties of 3 medicinal plants from Saudi Arabia against some clinical isolates of bacteria. Saudi Med J. 2012;33(3):272–277.
   PubMed Web of Science ®Google Scholar
• de Jonge N, Ross FM. Electron microscopy of specimens in liquid. Nat Nano. 2011;6(11):695–704.
   PubMed Web of Science ®Google Scholar
• Haschemyer RH, Meyers RJ. Negative staining. In: Hayat MA, editor. Principles and techniques of Electron Microscopy. Vol. 2, Biological Applications. New York: Van Nostrand Reinhold; 1972. p. 101–143.
   Google Scholar
• Ohi M, Li Y, Cheng Y, et al. Negative staining and image classification - powerful tools in modern electron microscopy. Biol Proced Online. 2004;6:23–34.
   PubMedGoogle Scholar
• Li H, Chen Q, Zhao J, et al. Enhancing the antimicrobial activity of natural extraction using the synthetic ultrasmall metal nanoparticles. Sci Rep. 2015 [cited 2017 Aug 07];5:11033. DOI:10.1038/srep11033
   PubMed Web of Science ®Google Scholar
• Hurdle JG, O' Neill AL, Chopra I, et al. Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections. Nature Rev Microbiol. 2011;9(1):62–75.
   PubMed Web of Science ®Google Scholar
• Agnihotri S, Mukherji S, Mukherji S. Size-controlled silver nanoparticles synthesized over the range 5–100 nm using the same protocol and their antibacterial efficacy. RSC Adv. 2014;4(8):3974–3983.
   Web of Science ®Google Scholar